RM and Genus: Markets live
RM (RM.) reported a 200% rise in half-year adjusted operating profit to £2.7mn despite revenue from continuing operations falling 4.2% to £70mn. The company cited restructuring and higher-margin assessment revenue, while UK education budgets and Middle East conflict weighed on tech and school supplies. Genus (GNS) said FY profit beat expectations, helped by PIC, and raised adjusted PBT guidance to £98mn vs £95.5mn consensus.
How this was made
The 30-second read
Why it matters
RM’s interim profitability improved materially and leverage fell, but the stock still dropped 3% on the interim results, suggesting investors discounted revenue softness or execution risk. Genus delivered better-than-expected FY profit and raised/confirmed adjusted PBT to £98m versus ~£95.5m consensus, supported by regional PIC strength.
Market read
Both names provide quantified interim/FY profit updates and guidance with explicit consensus comparison for Genus; RM’s leverage improvement is offset by revenue decline and a negative share reaction.
What to watch
Both stories emphasize restructuring and regional mix; traders may need to watch for follow-on commentary on cash conversion, debt paydown progress, and whether guidance assumes stabilization in the weaker segment.
Background
RM is an education technology firm undergoing a restructuring to simplify three divisions; Genus is an animal genetics company with a porcine business (PIC).
Ticker impact
RM reported a 200% jump in half-year adjusted operating profit to £2.7m despite revenue down 4.2%, plus leverage improving to 3.25x.
Likely modest positive bias for follow-through, with volatility given the revenue decline and the market reaction already negative.
The article provides quantified interim profit, leverage, and guidance intent, but also notes the shares fell 3%, implying investors weighed revenue softness or execution risk.
Genus guided adjusted profit before tax to £98m vs consensus ~£95.5m, citing stronger PIC performance in Asia and Latin America.
Near-term upside bias, with focus on whether North America weakness persists.
The article includes a specific guidance number, consensus comparison, and stated regional drivers, aligning with the reported 6% move.
Market effects
Highlights execution in education tech restructuring (RM) and animal genetics regional demand variability (Genus), but no direct sector-wide policy/regulatory catalyst.
Genus performance drivers explicitly cite Asia and Latin America strength offsetting North America weakness.
Limited; company-specific interim results and guidance with no stated cross-border macro shock.
Counterpoint
RM’s revenue decline and reliance on assessment segment strength could mean the profit improvement is not durable, while Genus’ North America “customer disease challenges” may re-accelerate downside.
Key entities
- companyRM
Education technology company reporting interim adjusted operating profit up 200% and leverage down to 3.25x.
- companyGenus
Animal genetics company guiding adjusted profit before tax to £98m, citing PIC strength in Asia and Latin America.
